Association Between Fetal Fraction and Positive Predictive Value of Noninvasive Prenatal Testing for Sex Chromosome Aneuploidies: A Retrospective Study of 68,290 Cases
This retrospective study of 68,290 cases demonstrates that while NIPT positive predictive values for sex chromosome aneuploidies vary significantly by subtype, fetal fraction is an independent predictor of true-positive results with a clear dose-response relationship, whereas maternal age and twin pregnancies show no significant association.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Pregnant women today often have access to a blood test that can look for certain chromosomal conditions in their developing baby without any risk of miscarriage. This test, known as noninvasive prenatal testing, works by analyzing tiny fragments of the baby's DNA that float freely in the mother's bloodstream. For common conditions involving three copies of a chromosome instead of two, this method is highly accurate. However, the test is less reliable when looking for abnormalities involving the sex chromosomes, which determine whether a baby is male or female. These conditions, such as having an extra X or Y chromosome, or missing an X chromosome, are harder to detect because the results can be confused by the mother's own DNA or by how the placenta develops. Because the physical effects of these conditions vary widely from person to person, knowing exactly how likely a positive result is to be true is critical for parents making difficult decisions.
A large team of researchers at the Guangdong Women and Children Hospital set out to clarify this uncertainty. They looked back at the records of nearly 69,000 pregnancies that had undergone this screening between 2020 and 2024. Among these, they identified 399 cases where the test flagged a potential sex chromosome issue. To find out which of these warnings were real, the researchers focused on the 276 women who agreed to follow up with invasive diagnostic procedures, such as amniocentesis, which can provide a definitive answer. By comparing the initial screening results with the final confirmed diagnoses, they calculated the true accuracy of the test for each specific type of sex chromosome condition.
The study revealed that the accuracy of the test depends heavily on which specific condition is being screened for. When the test suggested the baby had an extra Y chromosome, the result was correct 80% of the time. For an extra X chromosome in a male baby, the accuracy was about 63%, and for an extra X in a female baby, it was roughly 58%. However, when the test indicated a missing X chromosome, a condition known as Turner syndrome, the accuracy dropped significantly to just 19%. This means that in the vast majority of cases where the test flagged a missing X, the baby actually had a normal number of chromosomes. The researchers found that this high rate of false alarms for missing X chromosomes often stems from changes in the mother's own cells that occur naturally as she ages, rather than from the baby.
A key discovery in this research was the role of the amount of fetal DNA present in the mother's blood sample. The team found a clear pattern: the more fetal DNA in the sample, the more likely a positive result was to be correct. When the amount of fetal DNA was low, the chance of a true diagnosis was quite small. As the amount of fetal DNA increased, the likelihood of the condition being real grew steadily. For instance, when the fetal DNA made up at least 12% of the sample, the test was correct about 42% of the time, which is more than double the accuracy seen in samples with lower amounts. This suggests that the quantity of fetal DNA is a strong indicator of whether a warning sign is genuine.
Interestingly, the researchers found that the mother's age did not change the overall accuracy of the test in the way one might expect. While older mothers are generally at higher risk for having a baby with an extra chromosome due to errors in egg formation, this factor did not make the test more accurate for the group as a whole. This is because the age-related changes in the mother's own cells actually made the test less accurate for missing X chromosomes, effectively canceling out the benefits seen for other conditions. Similarly, the study looked at twin pregnancies and found that the test was less accurate for twins than for single babies, but the small number of twin cases in the study meant this finding was not statistically definitive.
The study concludes that while noninvasive testing is a powerful tool, it cannot replace invasive diagnostic procedures when a sex chromosome abnormality is suspected. The researchers emphasize that the amount of fetal DNA in the blood sample provides valuable context for doctors and parents. A high-risk result with a low amount of fetal DNA should be viewed with more caution than a result with a high amount. Ultimately, the findings help refine how medical professionals explain these results to families, ensuring they understand that a positive screen is not a final diagnosis, and that the specific type of condition and the amount of fetal DNA present are crucial factors in determining the true likelihood of the condition.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.